Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Clinical trial NCT07027072 · RECRUITING

Trial details

NCT number: NCT07027072
Sponsor: NeuroBiogen Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)Mild Dementia Alzheimer's Disease

Start date: 2025-08-06
Primary completion: 2027-06-30
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.